🔴 LifeMD is trading 14.14% down after delaying quarterly filing for accounting corrections

LifeMD is trading at $2.04, down 14.14%, after disclosing it needs more time to file its quarterly report while correcting prior-period revenue and expense recognition.

• The company identified previously overrecognized revenue and underrecognized expenses from earlier periods.
• It is reviewing potential effects on internal controls and expects to file by November 14.
• Corrections are not expected to affect cash or significantly change operating results versus the prior year, though preliminary conclusions could change.